Showing 13,841 - 13,860 results of 131,965 for search '(( a e decrease ) OR ( 5 ((((we decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 2.18s Refine Results
  1. 13841
  2. 13842
  3. 13843
  4. 13844
  5. 13845
  6. 13846
  7. 13847

    Minimal dataset. by Fatemeh Shahbazi (2271025)

    Published 2025
    “…The initial search was performed on January 28, 2024, and there were no restrictions on the time frame for the search. Ultimately, we employed a two-stage random effects model using the “drmeta” package in Stata software to perform this dose-response meta-analysis.…”
  8. 13848
  9. 13849
  10. 13850

    PCAIs inhibit NCI-H23 cell line viability. by Matthew D. Gregory (19929096)

    Published 2024
    “…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
  11. 13851

    PCAIs disrupt actin filaments in NCI-H23 cells. by Matthew D. Gregory (19929096)

    Published 2024
    “…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
  12. 13852

    PCAIs suppress 3D NCI-H23 cell invasion. by Matthew D. Gregory (19929096)

    Published 2024
    “…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
  13. 13853

    PCAIs suppress NCI-H23 cancer cell migration. by Matthew D. Gregory (19929096)

    Published 2024
    “…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
  14. 13854

    PCAIs induce apoptosis in NCI-H23 cells. by Matthew D. Gregory (19929096)

    Published 2024
    “…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
  15. 13855

    Hemodynamic parameters. by Paulina Kania-Olejnik (19797617)

    Published 2024
    “…Annular height marginally decreased with AF from 5.8±1.9mm to 5.7±2.0mm; <i>p</i> = 0.039.…”
  16. 13856

    Tricuspid annular dimensions. by Paulina Kania-Olejnik (19797617)

    Published 2024
    “…Annular height marginally decreased with AF from 5.8±1.9mm to 5.7±2.0mm; <i>p</i> = 0.039.…”
  17. 13857

    Regional tricuspid annular perimeter. by Paulina Kania-Olejnik (19797617)

    Published 2024
    “…Annular height marginally decreased with AF from 5.8±1.9mm to 5.7±2.0mm; <i>p</i> = 0.039.…”
  18. 13858
  19. 13859
  20. 13860